KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,762,000 | +60.3% | 17,000 | +21.4% | 0.21% | +42.5% |
Q1 2017 | $1,099,000 | +75.0% | 14,000 | 0.0% | 0.15% | +13.2% |
Q4 2016 | $628,000 | -19.7% | 14,000 | 0.0% | 0.13% | -8.5% |
Q3 2016 | $782,000 | +11.7% | 14,000 | 0.0% | 0.14% | +6.8% |
Q2 2016 | $700,000 | +8.9% | 14,000 | 0.0% | 0.13% | +12.8% |
Q1 2016 | $643,000 | – | 14,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |